Results 311 to 320 of about 295,622 (354)

Beta-Adrenergic Receptor Blockade

2018
David J. Goldberg, Robert E. Shaddy
openaire   +1 more source

Adrenergic receptor beta 1

AfCS-Nature Molecule Pages, 2005
openaire   +1 more source

Neutrino–nuclear responses for astro-neutrinos, single beta decays and double beta decays

Physics Reports, 2019
Jouni Suhonen, Hiroyasu Ejiri
exaly  

Beta-1-adrenergic-receptor-antagonists/beta-adrenergic-receptor-antagonists

Reactions Weekly
openaire   +1 more source

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

Lancet, The, 2003
Thor Petersen, Egon Stenager, Per Soelberg Sørensen   +2 more
exaly  

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Lancet, The, 2012
Jeffrey A Cohen, Alasdair J Coles, Douglas L Arnold   +2 more
exaly  

Beta-adrenergic receptors are different in subpopulations of human circulating lymphocytes.

Journal of Receptor Research, 1984
R. Landmann, E. Bürgisser, M. Wesp, F. Bühler   +3 more
semanticscholar   +1 more source

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

Lancet, The, 2007
Ludwig Kappos, Mark S Freedman, H-P Hartung   +2 more
exaly  

TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis

Lancet, The, 2003
Jan D Lunemann, Judith Bellmann-Strobl, Orhan Aktas   +2 more
exaly  

High affinity beta-2-adrenergic receptors in mononuclear leucocytes: similar density in young and old normal subjects.

Life Science, 1981
Regine Landmann, Helmut Bittiger, Fritz R. Bühler   +2 more
semanticscholar   +1 more source